- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 13.59M sh |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $8.25M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $3.04M |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $2.79M |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $2.82M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $15.99M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $22.98M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $15.4M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $51.93M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $50.08M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $79.81M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $72.52M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $85.87M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $79.82M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $103.37M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $99.79M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $139.18M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $130.48M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $300K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $300K |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 12.98M sh |
| Dividends Paid | Q1 2024 · Mar 31, 2023 | $438.45K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $3.76M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.11 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.11 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $1.64M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $1.12M |
| Net Income | Q1 2024 · Mar 31, 2023 | $1.45M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $2.37M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $5.52M |
| Revenue | Q1 2024 · Mar 31, 2023 | $22.15M |